AbbVie Inc. the Spinoff for 2013
AbbVie Inc (ABBV) just started trading in 2013. AbbVie is the first 'Spinoff' for Wall Street in the New Year and has separated from Abbott Labs (ABT).
AbbVie was the pharmaceutical division of Abbott Labs, so far its bounced from $34 to $35 per share. This spinoff has been in motion since 2011. Before the deal, Abbott was one of the largest healthcare companies in the world. The aging world population is going to keep popping pills made by AbbVie including the anti-inflammation drug Humira, the popular painkiller Vicodin, and cholesterol drug Niaspan.
Abbott's chairman and CEO Miles White called the event "the most transformative action" in the company's 125-history. AbbVie CEO Richard Gonzalez said that with his company's existing assets and focus on innovation "we intend to create significant value for our shareholders."
Bottom line: Time will tell if this spinoff will be successful and Wells Fargo is the first to set a price target of $33 to $34. For now add this stock to your watch list and as more information becomes available place your trading accordingly. To review the company check out their website at www.abbvie.com/
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Here Are BofA's "Trades Of The Unexpected" For June, The "Event Risk Month" | ZeroHedge
- How The Senate Just Took "A Hatchet To American Liberty" | ZeroHedge
- A Few Questions To Those Who Slam Gold | ZeroHedge
- Martin Armstrong Warns The Rise Of Nationalism Throughout Europe Is Inevitable | ZeroHedge
- Obama Steps In To Defend Hillary: DOJ Fights To Block Clinton Deposition | ZeroHedge
- The Task Confronting Libertarians | ZeroHedge
- First "Shocking" Deposition In Clinton Email Case Reveals She Did Not Use A Password | ZeroHedge
The most relevant financial news and articles from the Internets
- Canadian police raided dozens of Toronto pot shops amid... | Business Insider
- The legendary B-52 is about to get a lot more lethal | Business Insider
- The Best Business Schools of 2011 | BusinessWeek
- Saudi Arabia is 'backing away from OPEC' | Business Insider
- JOHN MAULDIN: An 'Alamo-like battle' is coming | Business Insider
- Over 100 top health experts think the Rio Olympics... | Business Insider
- Jawbone has stopped making its UP fitness trackers and sold remaining... | Business Insider